Abstract
Photoaffinity labeling techniques have been used for decades to identify drug binding sites and to study the structural biology of allosteric transitions in transmembrane proteins including pentameric ligand-gated ion channels (pLGIC). In a typical photoaffinity labeling experiment, to identify drug binding sites, UV light is used to introduce a covalent bond between a photoreactive ligand (which upon irradiation at the appropriate wavelength converts to a reactive intermediate) and amino acid residues that lie within its binding site. Then protein chemistry and peptide microsequencing techniques are used to identify these amino acids within the protein primary sequence. These amino acid residues are located within homology models of the receptor to identify the binding site of the photoreactive probe. Molecular modeling techniques are then used to model the binding of the photoreactive probe within the binding site using docking protocols. Photoaffinity labeling directly identifies amino acids that contribute to drug binding sites regardless of their location within the protein structure and distinguishes them from amino acids that are only involved in the transduction of the conformational changes mediated by the drug, but may not be part of its binding site (such as those identified by mutational studies). Major limitations of photoaffinity labeling include the availability of photoreactive ligands that faithfully mimic the properties of the parent molecule and protein preparations that supply large enough quantities suitable for photoaffinity labeling experiments. When the ligand of interest is not intrinsically photoreactive, chemical modifications to add a photoreactive group to the parent drug, and pharmacological evaluation of these chemical modifications become necessary. With few exceptions, expression and affinity-purification of proteins are required prior to photolabeling. Methods to isolate milligram quantities of highly enriched pLGIC suitable for photoaffinity labeling experiments have been developed. In this chapter, we discuss practical aspects of experimental strategies to identify allosteric modulator binding sites in pLGIC using photoaffinity labeling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Corringer PJ, Poitevin F, Prevost MS, Sauguet L, Delarue M, Changeux JP (2012) Structure and pharmacology of pentameric receptor channels: from bacteria to brain. Structure 20:941–956
Unwin N (2005) Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution. J Mol Biol 346:967–989
Hilf RJC, Dutzler R (2008) X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature 452:375–379
Bocquet N, Nury H, Baaden M, Le Poupon C, Changeux J-P, Delarue M, Corringer P-J (2009) X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457:111–114
Hibbs RE, Gouaux E (2011) Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474:54–60
Miller PS, Aricescu AR (2014) Crystal structure of a human GABAA receptor. Nature 512:270–275
Hassaine G, Deluz C, Grasso L, Wyss R, Tol MB, Hovius R, Graff A, Stahlberg H, Tomizaki T, Desmyter A, Moreau C, Li XD, Poitevin F, Vogel H, Nury H (2014) X-ray structure of the mouse serotonin 5-HT3 receptor. Nature 512:276–281
Jensen AA, Frolund B, Lijefors T, Krogsgaard-Larsen P (2005) Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48:4705–4745
Taly A, Corringer PJ, Guedin D, Lestage P, Changeux J-P (2009) Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 8:733–750
Hurst R, Rollema H, Bertrand D (2013) Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacol Ther 137:22–54
Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Sideri S, Zouridakis M, Tzartos SJ (2007) Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J 274:3799–3845
Rudolph U, Antkowiak B (2004) Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 5:709–720
Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685–697
Wu ZS, Cheng H, Jiang Y, Melcher K, Xu HE (2015) Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery. Acta Pharmacol Sin 36:895–907
Davies PA (2011) Allosteric modulation of the 5-HT3 receptor. Curr Opin Pharmacol 11:75–80
Burgos CF, Yévenes GE, Agudo LG (2016) Structure and pharmacological modulation of inhibitory glycine receptors. Mol Pharmacol 90:318–325
Meier J, NeunierDurmort C, Forest C, Triller A, Vannier C (2000) Formation of glycine receptor clusters and their accumulation at synapses. J Cell Sci 113:2783–2795
Dutertre S, Drwal M, Laube B, Betz H (2012) Probing the pharmacological properties of distinct subunit interfaces within heteromeric glycine receptors reveals a functional ββ agonist-binding site. J Neurochem 122:38–47
Gopalakrishnan M, Bertrand D, Williams M (2007) Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science. Biochem Pharmacol 74:1091
Williams DK, Wang J, Papke RL (2011) Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Biochem Pharmacol 82:915–930
Uteshev VV (2014) The therapeutic promise of positive allosteric modulation of nicotinic receptors. Eur J Pharmacol 727:181–185
Moroni M, Zwart R, Sher E, Cassels BK, Bermudez I (2006) α4β2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol 70:755–768
Young GT, Zwart R, Walker AS, Sher E, Millar NS (2008) Potentiation of a7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc Natl Acad Sci USA 105:14686–14691
Seo S, Henry JT, Lewis AH, Levandoski MM (2009) The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors. J Neurosci 29:8734–8742
Hamouda AK, Stewart DS, Husain SS, Cohen JB (2011) Multiple transmembrane binding sites for p-Trifluoromethyldiazirinyl-etomidate, a photoreactive torpedo nicotinic acetylcholine receptor allosteric inhibitor. J Biol Chem 286:20466–20477
Hamouda AK, Kimm T, Cohen JB (2013) Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor. J Neurosci 33:485–494
Olsen JA, Ahring PK, Kastrup JS, Gajhede M, Balle T (2014) Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at a4b2 nicotinic acetylcholine receptors. J Biol Chem 289:24911–24921
Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen E, Dam E, Jørgensen TD, Ahring PK, Peters D, Holst D, Christensen JK, Malysz J, Briggs CA, Gopalakrishnan M, Olsen GM (2007) An allosteric modulator of the a7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther 323:294–307
Timmermann DB, Sandager-Nielsen K, Dyhring T, Smith M, Jacobsen AM, Nielsen EO, Grunnet M, Christensen JK, Peters D, Kohlhaas K, Olsen GM, Ahring PK (2012) Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of alpha 2- and alpha 4-containing nicotinic acetylcholine receptors. Br J Pharmacol 167:164–182
Liu X (2013) Positive allosteric modulation of alpha 4 beta 2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration. Psychopharmacology (Berl) 230:203–213
Bagdas D, AlSharari SD, Freitas K, Tracy M, Damaj MI (2015) The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain. Biochem Pharmacol 97:590–600
Potasiewicz A, Kos T, Ravazzini F, Puia G, Arias HR, Popik P, Nikiforuk A (2015) Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the a7 nicotinic acetylcholine receptor. Br J Pharmacol 172:5123–5135
Abbas M, Rahman S (2016) Brain alpha-7 nicotinic acetylcholine receptor positive allosteric modulator attenuates mechanical allodynia and hyperalgesia in a mouse model of neuroinflammatory pain. J Pain 17:S75
Woll KA, Dailey WP, Brannigan G, Eckenhoff RG (2016) Shedding light on anesthetic mechanisms: application of photoaffinity ligands. Anesth Analg 132:1253–1262
Vodovozova EL (2007) Photoaffinity labeling and its application in structural biology. Biochemistry (Moscow) 72:1–20
Das J (2011) Aliphatic diazirines as photoaffinity probes for proteins : recent developments. Chem Rev 111:4405–4417
Hamouda AK, Jayakar SS, Chiara DC, Cohen JB (2014) Photoaffinity labeling of nicotinic receptors: diversity of drug binding sites! J Mol Neurosci 53:480–486
Middleton RE, Cohen JB (1991) Mapping of the acetylcholine binding site of the nicotinic acetylcholine receptor: [3H]-nicotine as an agonist photoaffinity label. Biochemistry 30:6987–6997
Dennis M, Giraudat J, Kotzyba-Hibert F, Goeldner M, Hirth C, Chang J-Y, Lazure C, Chrétien M, Changeux J-P (1988) Amino acids of the Torpedo marmorata acetylcholine receptor α-subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry 27:2346–2357
Chiara DC, Cohen JB (1997) Identification of amino acids contributing to high and low affinity d-Tubocurarine sites in the Torpedo nicotinic acetylcholine receptor. J Biol Chem 272:32940–32950
Wang D, Chiara DC, Xie Y, Cohen JB (2000) Probing the structure of the nicotinic acetylcholine receptor with 4- benzoylbenzoylcholine, a novel photoaffinity competitive antagonist. J Biol Chem 275:28666–28674
Chiara DC, Trinidad JC, Wang D, Ziebell MR, Sullivan D, Cohen JB (2003) Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-Diazirin-3-yl]Benzoylcholine, a novel photoaffinity antagonist. Biochemistry 42:271–283
Nirthanan S, Ziebell MR, Chiara DC, Hong F, Cohen JB (2005) Photolabeling the Torpedo Nicotinic acetylcholine receptor with 4-Azido-2,3,5,6-tetrafluorobenzoylcholine, a partial agonist. Biochemistry 44:13447–13456
Hamouda AK, Jin XC, Sanghvi M, Srivastava S, Pandhare A, Duddempudi PK, Steinbach JH, Blanton MP (2009) Photoaffinity labeling the agonist binding domain of α4β4 and α4β2 neuronal nicotinic acetylcholine receptors with [I-125]epibatidine and 5[I-125]A-85380. Biochim Biophys Acta 1788:1987–1995
Srivastava S, Hamouda AK, Pandhare A, Duddempudi PK, Sanghvi M, Cohen JB, Blanton MP (2009) [3H]Epibatidine photolabels non-equivalent amino acids in the agonist binding site of Torpedo and a4b2 nicotinic acetylcholine receptors. J Biol Chem 284:24939–24947
Giraudat J, Dennis M, Heidmann T, Chang J-Y, Changeux J-P (1986) Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: Serine-262 of the δ subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci USA 83:2719–2723
Revah F, Galzi JL, Giraudat J, Haumont P-Y, Lederer F, Changeux J-P (1990) The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor γ subunit: implications for the α-helical organization of regions MII and for the structure of the ion channel. Proc Natl Acad Sci USA 87:4675–4679
White BH, Cohen JB (1992) Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic non-competitive antagonist. J Biol Chem 267:15770–15783
Hamouda AK, Chiara DC, Blanton MP, Cohen JB (2008) Probing the structure of the affinity-purified and lipid-reconstituted Torpedo nicotinic acetylcholine receptor. Biochemistry 47:12787–12794
Chiara DC, Hamouda AK, Ziebell MR, Mejia LA, Garcia G, Cohen JB (2009) [3H]Chlorpromazine photolabeling of the Torpedo nicotinic acetylcholine receptor identifies two state-dependent binding sites in the ion channel. Biochemistry 48:10066–10077
Sawyer GW, Chiara DC, Olsen RW, Cohen JB (2002) Identification of the bovine γ-aminobutyric acid type A receptor α subunit residues photolabeled by the imidazobenzodiazepine [3H]Ro15-4513. J Biol Chem 277:50036–50045
Arevalo E, Chiara DC, Forman SA, Cohen JB, Miller KW (2005) Gating-enhanced accessibility of hydrophobic sites within the transmembrane region of the nicotinic acetylcholine receptor’s δ-subunit—A time-resolved photolabeling study. J Biol Chem 280:13631–13640
Li G-D, Chiara DC, Sawyer GW, Husain SS, Olsen RW, Cohen JB (2006) Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J Neurosci 26:11599–11605
Nirthanan S, Garcia GI, Chiara DC, Husain SS, Cohen JB (2008) Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector. J Biol Chem 283:22051–22062
Yamodo IH, Chiara DC, Cohen JB, Miller KW (2010) Conformational changes in the nicotinic acetylcholine receptor during gating and desensitization. Biochemistry 49:156–165
Chiara DC, Dostalova Z, Jayakar SS, Zhou X, Miller KW, Cohen JB (2012) Mapping general anesthetic binding site(s) in human α1β3 γ-Aminobutyric acid type A receptors with [3H]TDBzl-etomidate, a photoreactive etomidate analogue. Biochemistry 51:836–847
Jayakar SS, Dailey WP, Eckenhoff RG, Cohen JB (2013) Identification of propofol binding sites in a nicotinic acetylcholine receptor with a photoreactive propofol analog. J Biol Chem 288:6178–6189
Chiara DC, Yamodo HI, Miller KW, Cohen JB (2013) Structural differences in the nicotinic acetylcholine receptor (nACHR) ion channel between open and desensitized states revealed by time-resolved photolabeling with [3H]Chlorpromazine (CPZ). Biophys J 100:275a
Jayakar SS, Zhou X, Chiara DC, Dostalova Z, Savechenkov PY, Bruzik KS, Dailey W, Miller KW, Eckenhoff RG, Cohen JB (2014) Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog. J Biol Chem 289:27456–27468
Jayakar SS, Zhou X, Savechenkov PY, Chiara DC, Desai R, Bruzik KS, Miller KW, Cohen JB (2015) Positive and negative allosteric modulation of an α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor by binding to a site in the transmembrane domain at the γ+-β- interface. J Biol Chem 290:23432–23446
Abramson SN, Culver P, Klines T, Li Y, Guest P (1988) Lophotoxin and related coral toxins covalently label the α-subunit of the nicotinic acetylcholine receptor. J Biol Chem 263:18568–18573
Gallagher MJ, Cohen JB (1999) Identification of amino acids of the torpedo nicotinic acetylcholine receptor contributing to the binding site for the noncompetitive antagonist [H-3]tetracaine. Mol Pharmacol 56:300–307
Schrattenholz A, Godovac-Zimmermann J, Schafer HJ, Albuquerque EX, Maelicke A (1993) Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. Eur J Biochem 216:671–677
Hamouda AK, Wang ZJ, Stewart DS, Jain AD, Glennon RA, Cohen JB (2015) Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor. Mol Pharmacol 88:1–11
Hamouda AK, Deba F, Wang ZJ, Cohen JB (2016) Photolabeling a nicotinic acetylcholine receptor (nAChR) with an (α4)3(β2)2 nAChR-selective positive allosteric modulator. Mol Pharmacol 89:575–584
Brunner J (1993) New photolabeling and crosslinking methods. Annu Rev Biochem 62:483–514
Kotzyba-Hibert F, Kapfer I, Goeldner M (1995) Recent trends in photoaffinity labeling. Angew Chem Int Ed 34:1296–1312
Clement M, Martin SS, Beaulieu ME, Chamberland C, Lavigne P, Leduc R, Guillemette G, Escher E (2005) Determining the environment of the ligand binding pocket of the human angiotensin II type I (HAT(1)) receptor using the methionine proximity assay. J Biol Chem 280:27121–27129
Husain SS, Ziebell MR, Ruesch D, Hong F, Arevalo E, Kosterlitz JA, Olsen RW, Forman SA, Cohen JB, Miller KW (2003) 2-(3-methyl-3H-diaziren-3-yl) ethyl 1-(1-phenylethyl)-1H-imidazole-5- carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels. J Med Chem 46:1257–1265
Ziebell MR, Nirthanan S, Husain SS, Miller KW, Cohen JB (2004) Identification of binding sites in the nicotinic acetylcholine receptor for [H-3]azietomidate, a photoactivatable general anesthetic. J Biol Chem 279:17640–17649
Hamouda AK, Chiara DC, Sauls D, Cohen JB, Blanton MP (2006) Cholesterol interacts with transmembrane α-helices M1, M3, and M4 of the Torpedo nicotinic acetylcholine receptor: Photolabeling studies using [H-3-]azicholesterol. Biochemistry 45:976–986
Tomizawa M, Maltby D, Medzihradszky KF, Zhang NJ, Durkin KA, Presley J, Talley TT, Taylor P, Burlingame AL, Casida JE (2007) Defining nicotinic agonist binding surfaces through photoaffinity labeling. Biochemistry 46:8798–8806
Husain SS, Nirthanan S, Ruesch D, Solt K, Cheng Q, Li GD, Arevalo E, Olsen RW, Raines DE, Forman SA, Cohen JB, Miller KW (2006) Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels. J Med Chem 49:4818–4825
Hall MA, Xi J, Lor C, Dai S, Pearce R, Dailey WP, Eckenhoff RG (2010) m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol. J Med Chem 53:5667–5675
Savechenkov PY, Zhang X, Chiara DC, Stewart DS, Ge R, Zhou X, Raines DE, Cohen JB, Forman SA, Miller KW, Bruzik KS (2012) Allyl m-Trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic. J Med Chem 55:6554–6565
Chiara DC, Jayakar SS, Zhou X, Zhang X, Savechenkov PY, Bruzik KS, Miller KW, Cohen JB (2013) Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor. J Biol Chem 288:19343–19357
Hamouda AK, Stewart DS, Chiara DC, Savechenkov PY, Bruzik KS, Cohen JB (2014) Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]Allyl m-Trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate. Mol Pharmacol 85:735–746
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Bradford MM (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Sobel A, Weber M, Changeux J-P (1977) Large-scale purification of the acetylcholine-receptor protein in its membrane-bound and detergent extracted forms from Torpedo marmorata electric organ. Eur J Biochem 80:215–224
Pedersen SE, Dreyer EB, Cohen JB (1986) Location of ligand binding sites on the nicotinic acetylcholine receptor α-subunit. J Biol Chem 261:13735–13743
Fong TM, McNamee MG (1986) Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 25:830–840
daCosta CJB, Ogrel AA, McCardy EA, Blanton MP, Baenziger JE (2002) Lipid-protein interactions at the nicotinic acetylcholine receptor—a functional coupling between nicotinic receptors and phosphatidic acid-containing lipid bilayers. J Biol Chem 277:201–208
Hamouda AK, Sanghvi M, Chiara DC, Cohen JB, Blanton MP (2007) Identifying the lipid--protein interface of the α4β2 neuronal nicotinic acetylcholine receptor: hydrophobic photolabeling studies with 3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine. Biochemistry 46:13837–13846
Sanghvi M, Hamouda AK, Davis MI, Morton RA, Srivastava S, Pandhare A, Duddempudi PK, Machu TK, Lovinger DM, Cohen JB, Blanton MP (2009) Hydrophobic photolabeling studies identify the lipid–protein interface of the 5-HT3A receptor. Biochemistry 48:9278–9286
Dostalova Z, Liu AP, Zhou XJ, Farmer SL, Krenzel ES, Arevalo E, Desai R, Feinberg-Zadek PL, Davies PA, Yamodo IH, Forman SA, Miller KW (2010) High-level expression and purification of Cys-loop ligand-gated ion channels in a tetracycline-inducible stable mammalian cell line: GABA(A) and serotonin receptors. Protein Sci 19:1728–1738
Dostalova Z, Zhou X, Liu A, Zhang X, Zhang Y, Desai R, Forman SA, Miller KW (2014) Human α1β3γ2L γ-aminobutyric acid type A receptors: high-level production and purification in a functional state. Protein Sci 23:157–166
Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK (1977) Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem 252:1102–1106
Blanton MP, Cohen JB (1994) Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry 33:2859–2872
Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368–379
Schagger H (2006) Tricine–SDS-PAGE. Nat Protoc 1:16–22
Brauer AW, Oman CL, Margolies MN (1984) Use of ophthalaldehyde to reduce background during automated Edman degradation. Anal Biochem 137:134–142
Leite JF, Blanton MP, Shahgholi M, Dougherty DA, Lester HA (2003) Conformation-dependent hydrophobic photolabeling of the nicotinic receptor: electrophysiology-coordinated photochemistry and mass spectrometry. Proc Nat Acad Sci USA 100:13054–13059
Yip GMS, Chen ZW, Edge CJ, Smith EH, Dickinson R, Hohenester E, Townsend RR, Fuchs K, Sieghart W, Evers AS, Franks NP (2013) A propofol binding site on mammalian GABAA receptors identified by photolabeling. Nat Chem Biol 9:715–720
Chen ZW, Chen LH, Akentieva N, Lichti CF, Darbandi R, Hastings R, Covey DF, Reichert DE, Townsend RR, Evers AS (2012) A neurosteroid analogue photolabeling reagent labels the colchicine-binding site on tubulin: a mass spectrometric analysis. Electrophoresis 33:666–674
Kinde MN, Bu WM, Chen Q, Xu Y, Eckenhoff RG, Tang P (2016) Common anesthetic-binding site for inhibition of pentameric ligand-gated ion channels. Anesthesiology 124:664–673
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Jayakar, S.S., Ang, G., Chiara, D.C., Hamouda, A.K. (2017). Photoaffinity Labeling of Pentameric Ligand-Gated Ion Channels: A Proteomic Approach to Identify Allosteric Modulator Binding Sites. In: Kobeissy, F., Stevens, Jr., S. (eds) Neuroproteomics. Methods in Molecular Biology, vol 1598. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6952-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6952-4_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6950-0
Online ISBN: 978-1-4939-6952-4
eBook Packages: Springer Protocols